<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0079">
 <label>79</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Hashemy</surname>
    <given-names>SI</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ungerstedt</surname>
    <given-names>JS</given-names>
   </name>, 
   <name name-style="western">
    <surname>Avval</surname>
    <given-names>FZ</given-names>
   </name>, 
   <name name-style="western">
    <surname>Holmgren</surname>
    <given-names>A</given-names>
   </name>
  </person-group>
  <article-title>Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase</article-title>. 
  <source>J Biol Chem</source>
  <year>2006</year>;
  <volume>281</volume>:
  <fpage>10691</fpage>â€“
  <lpage>7</lpage>.
  <pub-id pub-id-type="pmid">16481328</pub-id>
 </mixed-citation>
</ref>
